Dechra Veterinary Products has picked up a major award at the 2011 Veterinary Marketing Awards for a calendar called 'The Horse in History'.

The calendar, designed to promote all of Dechra's equine products but particularly Equipalazone, also won…

Dechra Veterinary Products has launched Myorelax, a guaifenesin 100 mg/ml solution for infusion for horses which, the company says, relaxes skeletal muscles within minutes.

Dechra's Equine Brand Manager Emma Jennings said: "Myorelax is indicated for…

Dechra Veterinary Products has launched Anesketin, an anaesthetic licensed for cats, dogs and horses.

Anesketin contains ketamine 100mg/ml solution for injection and is indicated for induction of anaesthesia. In cats, it can also be used as a sole agent…

Dechra Veterinary Products has launched Osphos, an intramuscular clodronic acid injection for the control of clinical signs associated with the bone resorptive processes of navicular syndrome in horses, the only such licensed product in the UK.

Dechra…

Dechra Veterinary Products has launched Equibactin vet, a broad spectrum oral antibiotic paste that can be used to treat a wide range of infections in horses.

Equibactin vet contains sulfadiazine and trimethoprim, and is indicated for use in the treatment…

Dechra Veterinary Products has launched Ophtocycline (chlortetracycline hydrochloride), a broad spectrum ophthalmic antibiotic ointment for the treatment of a number of eye infections in dogs, cats and horses.

Ophtocycline is licensed for the treatment…

Dechra Veterinary Products has launched Tranquinervin, an injectable acepromazine for horses.

Tranquinervin, which contains 10 mg/ml acepromazine, is indicated for anaesthetic premedication, tranquilisation and sedation.

Emma Jennings, Brand Manager…

Dechra Veterinary Products has launched Rominervin, a new, fast-acting injectable solution for equine sedation and premedication.

Rominervin contains 10 mg/ml romifidine hydrochloride, equivalent to 8.76 mg romifidine, presented in a 20 ml vial.

It can be…

Dechra Veterinary Products has announced that it has acquired Dilaterol, the oral bronchodilator for horses, from the Dutch veterinary pharma company, LeVet.

Dilaterol is an oral syrup containing 25 mgs/ml clenbuterol hydrochloride, indicated to treat respiratory…

Dechra has launched Dormazolam (midazolam (5mg/ml), the first and only equine benzodiazepine licensed for the intravenous co-induction of anaesthesia in horses¹.

The company says Dormazolam works in synergy with other induction agents to provide an extended…

Dechra Veterinary Products has launched an apple-flavoured presentation of Equipalazone (phenylbutazone), its NSAID for horses and ponies. 

Equipalazone is most commonly used to treat lameness in equines and can be prescribed as a treatment for osteoarthritic…

Dechra has launched a 9g sachet version of its prednisolone treatment, Equisolon, for horses with severe equine asthma.

The oral corticosteroid powder formulation was previously only available in 180g tubs.

Severe equine asthma, which was previously known…

Dechra has launched Equibactin Powder (25mg sulfadiazine and 5mg trimethoprim), a new antibiotic powder designed to help prevent the under-dosing of larger horses being treated for bacterial infections.

Equibactin oral powder comes in a 60g sachet, which…

Dechra Veterinary Products has launched Strangvac, a protein-based strangles vaccine for horses and ponies.

Strangvac has been in development for over 25 years and Dechra says it's the first and only intramuscular vaccine to help protect against strangles…

Dechra has published the results of a survey which shows how vets and horse owners could do more to prevent strangles. 

The survey of 50 vets carried out in May this year¹ found that only half of them are recommending strangles vaccination to their clients…

Dechra has launched Equisolon Jar, a new presentation of its oral prednisone powder for the treatment of severe equine asthma.

Dechra says Equisolon is the only registered oral prednisolone powder that alleviates the inflammation and clinical parameters…

Dechra has launched Pergocoat, for the treatment of Pituitary Pars Intermedia Dysfunction (PPID), aka equine Cushing’s disease.

Pergocoat contains pergolide, a long-acting dopamine receptor agonist.

It is available in 0.5mg (off-white) and 1mg (yellow…